Klaus Geissler, Eva Jäger, Agnes Barna, Thamer Sliwa, Paul Knöbl, Ilse Schwarzinger, Heinz Gisslinger, Peter Valent. Is ruxolitinib a potentially useful drug in hematological malignancies with RAS pathway hyperactivation?. Haematologica 2016;101(12):e492-e492; https://doi.org/10.3324/haematol.2016.156448.